Dr Dennis Nishida, MD in Becker, MN - General Practice

Dr Dennis Nishida, MD is a General Practice physician based in Becker, Minnesota. Dr Dennis Nishida is licensed to practice in Minnesota (license number 38461) and his current practice location is 14505 River St, Becker, Minnesota. He can be reached at his office (for appointments etc.) via phone at (612) 801-5360.

NPI number for Dr Dennis Nishida is 1568792455 and his current mailing address is 14505 River St, Becker, Minnesota. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1568792455.

Contact Information

	Dr Dennis Nishida, MD
	14505 River St, Becker, MN 55308-4562
	(612) 801-5360
	Not Available

Physician's Profile

Full Name	Dr Dennis Nishida
Gender	Male
Speciality	General Practice
Location	14505 River St, Becker, Minnesota
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1568792455
Provider Enumeration Date: 12/28/2009
Last Update Date: 12/28/2009

Medical Identifiers

Medical identifiers for Dr Dennis Nishida such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1568792455	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	38461 (Minnesota)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Dennis Nishida is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Dennis Nishida, MD 14505 River St, Becker, MN 55308-4562 Ph: (612) 801-5360	Dr Dennis Nishida, MD 14505 River St, Becker, MN 55308-4562 Ph: (612) 801-5360

News Archive

New genomics research on abnormal brain development

Local researchers are finally on the road to developing targeted treatments for serious, life-long disabilities such as autism and schizophrenia, thanks to new genomics research focusing on abnormal brain development.

Lawmakers united against high drug prices bare partisan teeth

While the high cost of prescription drug prices seems to be a universally agreed-upon trouble spot in the American health system, a House Ways and Means subcommittee hearing Thursday showed that Democrats and Republicans are still miles apart on what to do about it.

Viewpoints: Insurance and death rates; Massachusetts 'exit plan'; Obamacare premiums

Alert (or at least health-care-obsessed) readers have no doubt been following the coverage of a new study on mortality in Massachusetts in the years following Romneycare's coverage expansion.

Canada's first nationwide hearing healthcare structure launched

Lifestyle Hearing Corporation has officially launched Canada's first nationwide hearing healthcare structure called the Lifestyle Hearing Network. This initiative aims to provide Canadians coast to coast with a consistent source of premium medical clinics devoted to audiology.

Pfizer, Protalix team up to develop and market plant-based enzyme for Gaucher's disease treatment

Pfizer and Protalix (NYSE-Amex: PLX) today announced that they have entered into an agreement to develop and commercialize taliglucerase alfa, a plant-cell expressed form of glucocerebrosidase (GCD) in development for the potential treatment of Gaucher's disease.

Dr Dennis Nishida, MD - General Practice in Becker, MN